Friday - April 26, 2024

Psoriatic Arthritis Pipeline Insights Report 2024 | Mylan, Celltrion, Fresenius Kabi, Pfizer, Fujifilm Kyowa Kirin Biologics,Amgen, Zydus cedilla, Sandoz, Shanghai Henlius Biotech and others

DelveInsight’s, “Psoriatic Arthritis Pipeline Insight 2024” report provides comprehensive insights about 50+ Psoriatic Arthritis companies and 50+ pipeline drugs in the Psoriatic Arthritis pipeline landscape. It covers the Psoriatic Arthritis pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Encephalopathy Pipeline Insights Report 2024 | Xenon Pharmaceuticals, Rebiotix, Axcella Health, Neurocrine Biosciences, and others.

DelveInsight’s, “Encephalopathy Pipeline Insight 2024” report provides comprehensive insights about 70+ Encephalopathy companies and 70+ pipeline drugs in the Encephalopathy pipeline landscape. It covers the Encephalopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading

Dry Age-Related Macular Degeneration Pipeline Insights Report 2024 | Molecular Partners, Stealth BioTherapeutics, Regenerative Patch Technologies, Aevitas Therapeutics, NGM Biopharmaceuticals

DelveInsight’s, “Dry Age-related Macular Degeneration Pipeline Insight 2024”  report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Cystic Fibrosis Pipeline Insights Report 2024 | Krystal Biotech, Vertex Pharmaceuticals, Translate Bio, Novartis, and others.

DelveInsight’s, “Cystic Fibrosis Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Cystic Fibrosis pipeline landscape. It covers the Cystic Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading